LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-alkynyl-estrenes and -estradienes, their production and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-aryl estradienes, processes for their production and ph

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-aryl-16.alpha.,17.alpha.-cyclohexano-estra-4,9-dienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-aryl-17, 17-spirothiolane-substituted steroids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-aryl-4-estrenes, process for their production as well a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-aryl-4-estrenes, process for their production as well a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-aryl-gona-4,9-dien-3-ones

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-arylestradienes, their production, and pharmaceutical p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-phenyl-14.beta.H steroids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-phenyl-4,9,15-estratrienes, their manufacture and pharm

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-substituted 14,17-ethanoestratrienes, process for their

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11.beta.-substituted 16.alpha., 17.alpha.-methylene-estra-4,9-di

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

13-alkyl-11.beta.-phenylgonanes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

13-alkyl-11beta-phenylgonanes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

13.alpha.-alkyl-gonanes, their production, and pharmaceutical pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14 β, 16, 17-methylene steroids as novel androgens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14&bgr;,15&bgr;-methylene-17&agr;-hydroxymethyl-androgens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14, 15-.&agr;.-methylene equilenine derivatives, methods for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14, 15-cyclopropanosteroids of the 19-norandrostane series,...